Загрузка...
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018
Omadacycline is a broad-spectrum aminomethylcycline approved in October 2018 by the U.S. Food and Drug Administration for treating acute bacterial skin and skin structure infections and community-acquired pneumonia as both an oral and intravenous once-daily formulation. In this report, the activitie...
Сохранить в:
| Опубликовано в: : | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7179604/ https://ncbi.nlm.nih.gov/pubmed/32071045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02488-19 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|